These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 15510184)
1. Clinical efficacy of Apomorphine SL in erectile dysfunction of diabetic men. Gontero P; D'Antonio R; Pretti G; Fontana F; Panella M; Kocjancic E; Allochis G; Frea B Int J Impot Res; 2005; 17(1):80-5. PubMed ID: 15510184 [TBL] [Abstract][Full Text] [Related]
2. Erection hardness: a unifying factor for defining response in the treatment of erectile dysfunction. Mulhall JP; Levine LA; Jünemann KP Urology; 2006 Sep; 68(3 Suppl):17-25. PubMed ID: 17011372 [TBL] [Abstract][Full Text] [Related]
3. Evaluating dose regimens of apomorphine, an open-label study. Kongkanand A; Opanuraks J; Tantiwongse K; Choeypunt N; Tantiwong A; Amornvejsukit T Int J Impot Res; 2003 Apr; 15 Suppl 2():S10-2. PubMed ID: 12825098 [TBL] [Abstract][Full Text] [Related]
4. A European multicentre study to evaluate the tolerability of apomorphine sublingual administered in a forced dose-escalation regimen in patients with erectile dysfunction. Von Keitz AT; Ströberg P; Bukofzer S; Mallard N; Hibberd M BJU Int; 2002 Mar; 89(4):409-15. PubMed ID: 11872034 [TBL] [Abstract][Full Text] [Related]
5. Comparison of international index of erectile function with nocturnal penile tumescence and rigidity testing in evaluation of erectile dysfunction. Tokatli Z; Akand M; Yaman O; Gulpinar O; Anafarta K Int J Impot Res; 2006; 18(2):186-9. PubMed ID: 16151473 [TBL] [Abstract][Full Text] [Related]
6. Tolerability and safety of apomorphine SL (Ixense (TM) ). Montorsi F Int J Impot Res; 2003 Apr; 15 Suppl 2():S7-9. PubMed ID: 12825097 [TBL] [Abstract][Full Text] [Related]
7. Characterising the benefit of apomorphine SL (Uprima) as an optimised treatment for representative populations with erectile dysfunction. Heaton JP Int J Impot Res; 2001 Aug; 13 Suppl 3():S35-9. PubMed ID: 11477490 [TBL] [Abstract][Full Text] [Related]
8. Erectile function and assessments of erection hardness correlate positively with measures of emotional well-being, sexual satisfaction, and treatment satisfaction in men with erectile dysfunction treated with sildenafil citrate (Viagra). Montorsi F; Padma-Nathan H; Glina S Urology; 2006 Sep; 68(3 Suppl):26-37. PubMed ID: 17011373 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of on-demand tadalafil for the treatment of erectile dysfunction in South-East Asian men. Guo YL; Zhu JC; Pan TM; Ding Q; Wang YX; Cheong NF; Lim E; Shen W; Venugopalan M; Chan M Int J Urol; 2006 Jun; 13(6):721-7. PubMed ID: 16834650 [TBL] [Abstract][Full Text] [Related]
10. Sildenafil citrate for erectile dysfunction in men with diabetes and cardiovascular risk factors: a retrospective analysis of pooled data from placebo-controlled trials. Blonde L Curr Med Res Opin; 2006 Nov; 22(11):2111-20. PubMed ID: 17076971 [TBL] [Abstract][Full Text] [Related]
11. Efficacy, safety, and treatment satisfaction of tadalafil versus placebo in patients with erectile dysfunction evaluated at tertiary-care academic centers. Carson C; Shabsigh R; Segal S; Murphy A; Fredlund P; Kuepfer C; Urology; 2005 Feb; 65(2):353-9. PubMed ID: 15708052 [TBL] [Abstract][Full Text] [Related]
12. An open-label, uncontrolled dose-optimization study of sublingual apomorphine in erectile dysfunction. Mulhall JP; Bukofzer S; Edmonds AL; George M; Clin Ther; 2001 Aug; 23(8):1260-71. PubMed ID: 11558862 [TBL] [Abstract][Full Text] [Related]
13. Oral treatment of erectile dysfunction with apomorphine SL. Altwein JE; Keuler FU Urol Int; 2001; 67(4):257-63. PubMed ID: 11741126 [TBL] [Abstract][Full Text] [Related]
14. A comparative, crossover study of the efficacy and safety of sildenafil and apomorphine in men with evidence of arteriogenic erectile dysfunction. Perimenis P; Gyftopoulos K; Giannitsas K; Markou SA; Tsota I; Chrysanthopoulou A; Athanasopoulos A; Barbalias G Int J Impot Res; 2004 Feb; 16(1):2-7. PubMed ID: 14963464 [TBL] [Abstract][Full Text] [Related]
15. Double-blind, crossover comparison of 3 mg apomorphine SL with placebo and with 4 mg apomorphine SL in male erectile dysfunction. Dula E; Bukofzer S; Perdok R; George M; Eur Urol; 2001 May; 39(5):558-3; discussion 564. PubMed ID: 11464037 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of vardenafil in Asian men with erectile dysfunction. Tan HM; Chin CM; Chua CB; Gatchalian E; Kongkanand A; Moh CL; Ng FC; Ratana-Olarn K; Serrano D; Taher A; Tambi I; Tantiwong A; Chen MW; Yip WC Asian J Androl; 2008 May; 10(3):495-502. PubMed ID: 18385912 [TBL] [Abstract][Full Text] [Related]
17. Placebo-controlled study on efficacy and safety of daily apomorphine SL intake in premenopausal women affected by hypoactive sexual desire disorder and sexual arousal disorder. Caruso S; Agnello C; Intelisano G; Farina M; Di Mari L; Cianci A Urology; 2004 May; 63(5):955-9. PubMed ID: 15134988 [TBL] [Abstract][Full Text] [Related]
18. Safety and tolerability of apomorphine SL (Uprima). Bukofzer S; Livesey N Int J Impot Res; 2001 Aug; 13 Suppl 3():S40-4. PubMed ID: 11477491 [TBL] [Abstract][Full Text] [Related]
19. Comparable efficacy of once-daily versus on-demand vardenafil in men with mild-to-moderate erectile dysfunction: findings of the RESTORE study. Zumbé J; Porst H; Sommer F; Grohmann W; Beneke M; Ulbrich E Eur Urol; 2008 Jul; 54(1):204-10. PubMed ID: 18395326 [TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of sildenafil citrate in treating erectile dysfunction in patients with combat-related post-traumatic stress disorder: a double-blind, randomized and placebo-controlled study. Safarinejad MR; Kolahi AA; Ghaedi G BJU Int; 2009 Aug; 104(3):376-83. PubMed ID: 19389004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]